Share

Access to Health Care

ACS CAN advocates for policies that provide access to treatments and services people with cancer need for their care - including those who may be newly diagnosed, in active treatment and cancer survivors.

Prescription Drug Affordability Resources:

A majority of cancer patients and survivors struggle to afford cancer care and over 80% have had to make financial sacrifices to cover their health care expenses. This survey also reveals ways that affordability concerns can negatively impact care and treatment, and explores issues related to prescription drug coverage and pain management options.

Many cancer patients take multiple drugs as part of their treatment – often for many months or years. While drugs are not the only costly part of cancer treatment, finding ways to reduce these costs for patients and payers will significantly reduce the overall cost burden of cancer.

This Survivor Views survey examined access to and affordability of cancer care. Survivors report insurance-related barriers to obtaining prescriptions, and lower-income respondents in particular have difficulty affording them.  24% of respondents have received a surprise medical bill, 60% of which were more than $500.

Biological drugs, commonly referred to as biologics, are a class of drugs that are produced using a living system, such as a microorganism, plant cell, or animal cell. Like all drugs, biologics are regulated by the United States Food and Drug Administration (FDA).

For an individual with specific health care needs – like cancer patients and survivors – the drugs covered by a health plan and corresponding cost sharing for each drug is important information when choosing health insurance. However, to make an informed choice, formulary information must be disclosed to the individual.

  •  

Private Health Insurance Resources:

ACS CAN supports the administration’s goal of improving market integrity and we are committed to policies that effectively address any waste, fraud, and abuse that exists in public health care programs.

This factsheet provides information on how the enhanced ACA tax credits help states. 

The American Cancer Society Cancer Action Network (ACS CAN) appreciates the opportunity to comment on the Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters (NBPP) for plan year 2026.

This factsheet provides background information on why Congress must act swiftly to extend the enhanced ACA tax credits. 

In our latest survey, cancer patients and survivors overwhelmingly support extending financial assistance for people who purchase health coverage through the Affordable Care Act marketplace by a margin of nearly 12 to 1 (72% support, 6% oppose). The survey also finds 43% would not be able to afford their plan without the enhanced tax credits, 30% would skip or delay medical care to reduce expenses, and 24% would accumulate medical debt to afford their care.

On Thursday, March 30, 2023, Judge O’Connor released a final opinion on remedies in Braidwood Management vs.

Cancer patients and survivors must balance reducing their health care costs with ensuring they have comprehensive coverage of services, treatments, and care providers.

ACS CAN submitted comments regarding marketplace insurance plans and requirements for plan year 2023. 

High deductible health plans (HDHPs) and health savings accounts (HSAs) are becoming more common in employer-sponsored insurance and the individual and small group markets.  These types of plans have risks and features must be implemented carefully so they do not harm cancer patients, survivors or those at risk for cancer.

Costs and Barriers to Care Resources:

Consumers need access to health insurance policies that cover a full range of evidence-based health care services – including prevention and primary care – necessary to maintain health, avoid disease, overcome acute illness and live with chronic disease.  Any health care system that works for cancer patients must have standards ensuring that enrollees have access to comprehensive health insurance.

Current federal requirements prohibit most insurance plans from limiting both the lifetime and annual dollar value of benefits.  This ban is one of several important patient protections that must be part of any health care system that works for cancer patients.

 

 

  •  

Medicaid Resources:

Medicaid is a critical source of health insurance and coverage for more than 77 million Americans, including people with cancer who rely on the program for prevention, timely detection, treatment, and survival. The 2025 budget reconciliation bill makes significant changes to key Medicaid funding mechanisms like state-directed payments and provider taxes, which are expected to reduce states’ ability to finance their Medicaid programs. This factsheet outlines what these changes mean, the projected financial impact on states, and consequences for patient access to cancer care.

ACS CAN submitted comments to CMS opposing Montana's 1115 waiver application to implement work requirements and premiums in their Medicaid program.

ACS CAN opposes policies that condition Medicaid enrollment on work or reporting of work. 

ACS CAN opposes Utah’s proposal to implement work requirements in its Medicaid program, and we urge CMS to reject the amendment request.

ACS CAN supports this demonstration application and urges the Centers for Medicare and Medicaid Services to approve it.

While ACS CAN supports South Carolina expanding Medicaid, we oppose the current proposal for a severely limited expansion with work requirements and an enrollment cap. We urge CMS to reject this proposal.

ACS CAN opposes the extension of Iowa Medicaid's Wellness demonstration, which is now proposed to include a work requirement.

Medicaid provides access to life-saving care for people in America fighting cancer, especially low-income individuals primarily from rural and underserved communities.